Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
Home
ETF
OCGN
OCGN
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
OCGN News
Avaí Bio Advances Cell Therapy for Aging
6d ago
PRnewswire
Avaí Bio and Austrianova Advance Anti-Aging Therapy Collaboration
6d ago
Newsfilter
Ocugen Completes Enrollment for OCU410ST Clinical Trial
Apr 01 2026
Newsfilter
Ocugen Reports Phase 2 Data for OCU410 Gene Therapy
Mar 24 2026
seekingalpha
OCGN Stock Plummets Following Gene Therapy Trial News — What Did Ocugen Reveal?
Mar 24 2026
stocktwits
Canaccord Genuity Initiates Buy on Ocugen with $12 Price Target
Mar 18 2026
seekingalpha
Ocugen's Three Clinical Programs Rated Buy by Analysts
Mar 17 2026
stocktwits
Major Averages Decline Amid Oil Price Volatility
Mar 12 2026
Yahoo Finance
Ocugen Shares Surge After Oppenheimer Initiates Coverage with Outperform Rating
Mar 11 2026
Benzinga
Ocugen Shares Hit 52-Week High Following Oppenheimer Outperform Rating
Mar 11 2026
seekingalpha
Serve Robotics Shares Surge After Strong Q4 Results and Upgraded Sales Guidance
Mar 11 2026
Benzinga
Ocugen Reports Q4 and Full-Year 2025 Financial Results
Mar 05 2026
NASDAQ.COM
Ocugen Q4 2025 Earnings Call Insights Highlight Growth and Strategic Developments
Mar 04 2026
seekingalpha
Ocugen Reports Q4 2025 Financial Results
Mar 04 2026
seekingalpha
OCUGEN REPORTS Q4 NET LOSS OF USD 17.706 MILLION
Mar 04 2026
moomoo
OCUGEN REPORTS Q4 OPERATING EXPENSES OF $16.802 MILLION
Mar 04 2026
moomoo
Show More News
